How does glucagon work

Overview

Glucagon is a crucial peptide hormone that plays a fundamental role in glucose homeostasis, working in opposition to insulin to maintain blood sugar levels within a healthy range. Discovered in 1923 by physiologist John R. Murlin and his colleagues at the University of Rochester, glucagon was identified as a hyperglycemic factor in pancreatic extracts. The name "glucagon" derives from "glucose agonist," reflecting its primary function of raising blood glucose. This 29-amino acid hormone is synthesized as proglucagon and processed in pancreatic alpha cells, which constitute approximately 15-20% of the islet cell population. Historically, glucagon's discovery emerged from research on insulin, as scientists noticed that pancreatic extracts sometimes caused hyperglycemia rather than hypoglycemia. The hormone's structure was fully elucidated in the 1950s, and its receptor was cloned in the 1990s, leading to significant advances in understanding glucose regulation. Today, glucagon is recognized as part of the incretin hormone family and plays essential roles in metabolic regulation beyond glucose control.

How It Works

Glucagon functions through a well-defined molecular mechanism that begins when blood glucose levels drop below approximately 70 mg/dL (3.9 mmol/L). The hormone binds to specific G-protein coupled receptors on hepatocytes (liver cells), activating adenylate cyclase. This enzyme converts ATP to cyclic AMP (cAMP), which serves as a second messenger. Increased cAMP levels activate protein kinase A, which in turn phosphorylates and activates phosphorylase kinase. This enzyme then phosphorylates glycogen phosphorylase, converting it to its active form. Active glycogen phosphorylase catalyzes the breakdown of glycogen to glucose-1-phosphate through glycogenolysis. The glucose-1-phosphate is converted to glucose-6-phosphate and then to free glucose, which is released into the bloodstream. Additionally, glucagon stimulates gluconeogenesis by increasing the transcription of phosphoenolpyruvate carboxykinase and glucose-6-phosphatase genes. The hormone also inhibits glycolysis and promotes lipolysis in adipose tissue. Glucagon secretion is regulated by multiple factors including low blood glucose, amino acids (particularly arginine and alanine), sympathetic nervous system activation, and certain hormones like epinephrine.

Why It Matters

Glucagon's significance extends across clinical medicine, diabetes management, and metabolic research. In clinical practice, glucagon injections are lifesaving interventions for severe hypoglycemia, particularly in people with diabetes who may experience dangerously low blood sugar. The American Diabetes Association reports that approximately 100,000 emergency room visits annually in the United States involve severe hypoglycemia, many requiring glucagon administration. Beyond emergency use, glucagon receptor antagonists are being investigated as potential treatments for type 2 diabetes. The hormone also plays a crucial role in metabolic disorders; excessive glucagon secretion contributes to the hyperglycemia seen in diabetes, while glucagon deficiency can cause hypoglycemia. In research, understanding glucagon signaling has advanced our knowledge of metabolic regulation and informed the development of dual-agonist drugs that target both glucagon and GLP-1 receptors for obesity and diabetes treatment. Furthermore, glucagon's role in regulating hepatic glucose production makes it a key focus in studies of metabolic syndrome and non-alcoholic fatty liver disease.